Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,Whats new CLL KC

    New case-based chronic lymphocytic leukaemia
    CME module

    A new CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been
    added to the CLL Knowledge Centre on epgonline.org. Read case studies and improve
    your knowledge of CLL by answering quiz questions based on a variety of scenarios. This
    module has been EACCME-accredited and is worth 1 European CME credit. There is no cost
    to complete this educational activity.

  • ,Hypogonadism Relaunch Whats New

    Launch of updated Hypogonadism Knowledge Centre

    Our Hypogonadism Knowledge Centre contains important disease awareness
    information to support healthcare professionals in the current best practice
    treatment and management of male hypogonadism and is available to access free of
    charge. Sections cover epidemiology, pathophysiology, signs and symptoms, treatment
    options, as well as useful resources and a regularly updated publications digest.

    G.MKT.GM.MH.01.2016.0364

  • ,

    New Type 2 Diabetes CME now available

    A new CME activity ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in
    Combination with Insulin’ has been added to the Type 2 Diabetes Learning Zone.
    Complete the five modules to enhance your understanding of the combination
    therapies available for treating type 2 diabetes.

  • ,COPD whats new ATS 2015

    ATS 2015 symposium materials added to
    COPD Knowledge Centre

    Speaker slides and a video from the Novartis-sponsored symposium ‘Are we gaining the
    maximum benefit from bronchodilators in COPD?’ have been added to the COPD Knowledge
    Centre. The session was held at the American Thoracic Society (ATS) conference 2015 to
    highlight the fundamental role of bronchodilators in COPD management, and presented
    key drug data including efficacy and safety of some of the latest COPD therapies.

  • ,Whats New CSU

    Updates to Chronic Spontaneous Urticaria
    Knowledge Centre

    Video presentations of faculty experts speaking at the 23rd World Congress of
    Dermatology (WCD) 2015 have been added to the Chronic Spontaneous Urticaria (CSU)
    Knowledge Centre. Topics discussed include diagnosis, burden and an overall clinical
    picture of urticaria.

Latest News

Abbott Laboratories acquires Kalila Medical and with it the Vado steerable sheath

08-Feb-2016

Abbott Laboratories, a healthcare company, has acquired Kalila Medical, Inc., a developer of next-generation access technologies used in cardiac electrophysiology procedures for the treatment of heart rhythm disorders, including atrial fibrillation. ...

FDA approves Amplia MRI Quad CRT-D SureScan and Compia MRI Quad CRT-D SureScan systems for heart failure- Medtronic

07-Feb-2016

The FDA has approved Medtronic Amplia MRI Quad CRT-D SureScan and Compia MRI Quad CRT-D SureScan systems for the treatment of heart failure. These magnetic resonance imaging (MRI) conditional cardiac resynchronization therapy defibrillators (CRT-Ds) ...

Phase III data on Solitaire (solithromycin oral capsules) in community-acquired bacterial pneumonia- Cempra

07-Feb-2016

Cempra has announced the publication of positive results from its pivotal Phase III clinical trial of Solitaire (solithromycin oral capsules) in the treatment of patients with community-acquired bacterial pneumonia (CABP) in The Lancet Infectious ...

FDA extends approval in Daklinza (daclatasvir) plus Sovaldi (sofosbuvir) to genotypes 1 and 3 chronic hepatitis C- BMS

07-Feb-2016

Bristol-Myers Squibb announced that the FDA has expanded approval of Daklinza (daclatasvir, 60 mg), in combination with Sovaldi (sofosbuvir) with or without ribavirin, to patients with genotypes 1 and 3 chronic hepatitis C. The expanded label ...

Phase III TOWER study of Blincyto (blinatumomab)in Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia, ends early for efficacy.-Amgen

06-Feb-2016

Amgen has announced that the results of a prespecified interim analysis showed that the primary endpoint of improved overall survival was met in the Phase III TOWER study. The randomized, open-label TOWER study evaluated the efficacy of Blincyto ...

Phase III GAUSS-3 trial evaluating Repatha (evolocumab) meets endpoints in cholesterol reduction- Amgen

06-Feb-2016

Amgen has announced that the Phase III GAUSS-3 trial evaluating Repatha (evolocumab) in patients with high cholesterol who cannot tolerate statins met its co-primary endpoints: mean percent reductions from baseline in low-density lipoprotein ...

FDA advisory committee supports sNDA for Brintellix (vortioxetine) in major depressive disorder- Takeda/Lundbeck

05-Feb-2016

Takeda Pharmaceutical and Lundbeck have announced that the FDA's Psychopharmacologic Drugs Advisory Committee (PDAC) voted 8 to 2 that the companies presented substantial evidence to support the effectiveness of Brintellix (vortioxetine) for ...

Recent Updates

Drugs

Clinical Guidelines

Care of dying adults in the last days of life

Intravenous fluid therapy in children and young people in hospital

Type 2 diabetes: The management of type 2 diabetes

Children’s attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care

Medical Journals

Psoriasis

Imatinib: a breakthrough of targeted therapy in cancer.

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages

News

News

News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors